Epizyme reported $-29806000 in Operating Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbott ABT:US $ 2388M 524M
Agios Pharmaceuticals AGIO:US $ -94.94M 3.5M
Amarin AMRN:US $ -62.83M 34.52M
Amgen AMGN:US $ 2176M 324M
Avrobio Inc AVRO:US -27774000 1.64M
Biogen BIIB:US $ -59.1M 669.8M
Bluebird Bio BLUE:US $ -107.4M 12.95M
Cerulean Pharma CERU:US $ -8400450 1.14M
Daiichi Sankyo 4568:JP Y 34382M 85129M
Eisai 4523:JP Y 7434M 28237M
Epizyme EPZM:US $ -29806000 21.12M
Exelixis EXEL:US $ 83.71M 0.46M
Gilead Sciences GILD:US $ 2029M 1832M
GlaxoSmithKline GSK:LN 1.08B 1.72B
Glaxosmithkline GSK:US $ 1081M 1720M
IONIS PHARMACEUT IONS:US $ -85.51M 28.01M
Karyopharm Therapeutics KPTI:US $ -42908000 8.32M
Macrogenics MGNX:US $ -41808000 24.83M
Merk MRK:US $ 4927M 642M
Mirati Therapeutics MRTX:US $ -177.2M 7.01M
Novartis NOVN:VX 2.23B 624M
Novartis NVS:US $ 2228M 624M
Pfizer PFE:US $ 12102M 2229M
Regeneron Pharmaceuticals REGN:US $ 1109.9M 148.6M
Seattle Genetics SGEN:US $ -133.11M 0.06M
Spectrum Pharmaceuticals SPPI:US $ -25.39M 11.33M
Vertex Pharmaceuticals VRTX:US $ 1106.3M 65.4M
Xencor XNCR:US $ -28M 54.47M